Dr. Esther M. Alegria has been a director of STERIS since 2023 and chairs the Compliance and Technology Committee while also serving on the Nominating and Governance Committee. She has more than 25 years of biopharmaceutical experience advancing vaccines and therapeutic drugs from R&D through commercialization, and currently serves as an Executive Consultant and Advisor with The LaSalle Group.